4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-035936
VP Clinical Reg Affairs bought 250 shares at $12.94 ($3,235)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Jaye VP Clinical Reg Affairs | 2022-12-16 | Purchase | +250 | $12.94 | $3,235 | 256,495 | D |
| Open-market purchases · 250 sh · avg $12.94 · $3,235 | |||||||
Loading xslF345X03/ownership.xml…